Lanzhou Foci Pharmaceutical Co Ltd Strategic Asset Allocation Index
Lanzhou Foci Pharmaceutical Co Ltd strategic asset allocation index. Lanzhou Foci Pharmaceutical Co Ltd (002644) has a Strategic Asset Allocation Index of 59.1% as of September 2023. Strategic assets (PP&E of CN¥1.04 Billion plus long-term investments of CN¥-) total CN¥1.04 Billion, measured against net assets of CN¥1.77 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Lanzhou Foci Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Lanzhou Foci Pharmaceutical Co Ltd (2008–2021)
Strategic asset allocation index of Lanzhou Foci Pharmaceutical Co Ltd from 2008 to 2021. This chart shows how Lanzhou Foci Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of September 2023, the index stands at 59.1%, representing strategic assets of CN¥1.04 Billion against net assets of CN¥1.77 Billion CNY. Check 002644 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Lanzhou Foci Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2008–2021)
Lanzhou Foci Pharmaceutical Co Ltd strategic asset allocation index by year from 2008 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Lanzhou Foci Pharmaceutical Co Ltd from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Lanzhou Foci Pharmaceutical Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 67.1% | CN¥1.09 Billion | CN¥1.09 Billion | CN¥- | CN¥1.63 Billion | ▼ -2.9 pp |
| 2020 | 70.0% | CN¥1.11 Billion | CN¥1.11 Billion | CN¥- | CN¥1.59 Billion | ▲ +5.5 pp |
| 2019 | 64.5% | CN¥971.63 Million | CN¥971.63 Million | CN¥- | CN¥1.51 Billion | ▼ -23.4 pp |
| 2018 | 87.9% | CN¥1.27 Billion | CN¥1.22 Billion | CN¥42.50 Million | CN¥1.44 Billion | ▲ +6.9 pp |
| 2017 | 80.9% | CN¥1.10 Billion | CN¥1.10 Billion | CN¥- | CN¥1.36 Billion | ▲ +44.4 pp |
| 2016 | 36.5% | CN¥471.22 Million | CN¥471.22 Million | CN¥- | CN¥1.29 Billion | ▲ +21.3 pp |
| 2015 | 15.2% | CN¥187.78 Million | CN¥187.78 Million | CN¥- | CN¥1.23 Billion | ▼ -7.5 pp |
| 2014 | 22.7% | CN¥167.04 Million | CN¥167.04 Million | CN¥- | CN¥735.22 Million | ▼ -19.1 pp |
| 2013 | 41.8% | CN¥294.12 Million | CN¥294.12 Million | CN¥- | CN¥703.37 Million | ▲ +2.2 pp |
| 2012 | 39.6% | CN¥267.76 Million | CN¥267.76 Million | CN¥- | CN¥675.53 Million | ▲ +11.4 pp |
| 2011 | 28.3% | CN¥183.16 Million | CN¥183.16 Million | CN¥- | CN¥648.08 Million | ▼ -18.2 pp |
| 2010 | 46.5% | CN¥151.69 Million | CN¥151.69 Million | CN¥- | CN¥326.46 Million | ▼ -7.7 pp |
| 2009 | 54.2% | CN¥137.04 Million | CN¥137.04 Million | CN¥- | CN¥252.96 Million | ▼ -8.6 pp |
| 2008 | 62.7% | CN¥136.04 Million | CN¥136.04 Million | CN¥- | CN¥216.81 Million | — |